Skip to content

Cerebral Reorganization in Cervical Myelopathy Measured by Navigated Transcranial Magnetic Stimulation

Cerebral Reorganization in Cervical Myelopathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03312608
Acronym
CReMe
Enrollment
160
Registered
2017-10-18
Start date
2017-01-01
Completion date
2023-02-01
Last updated
2017-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Myelopathy

Keywords

cerebral reorganization, TMS

Brief summary

In degenerative cervical myelopathy (DCM) the dynamics of disease progression and the outcome after surgical decompression vary inter individually and do not necessarily correlate with radiological findings. By better characterization of the underlying pathophysiology this study aims to improve diagnostic power in DCM using Navigated transcranial magnetic stimulation (nTMS).

Detailed description

120 patients with DCM due to cervical spinal canal stenosis will be examined preoperatively and postoperatively with nTMS. On the basis of the initial Japanese Orthopedic Association (JOA) Score two patient groups will be established (JOA≤12/\>12). The resting motor threshold, recruitment curve, cortical silent period and motor area will be determined. Accordingly, 40 healthy subjects will be examined. To the investigators knowledge, this study is the first to analyze changes of corticospinal excitability and reorganization in patients with cervical spondylotic myelopathy with navigated TMS. In the present study, there was a significant difference in parameters of excitability and motor area activation between the severely symptomatic and clinically stable patient group. The investigators analysis showed that chronic CSM induces a recruitment of the non-primary motor area and corticospinal disinhibition, so that axonal damage can be compensated through recruitment of new cortical and supplementary motor connections, to a certain degree. Upon exhaustion of these mechanisms further axonal damage translates directly into new neurological deficits. These results lay the ground for a novel concept in CSM, the corticospinal reserve capacity. This study lays the foundation for future research to examine the pathomechanisms in CSM. Functional reorganization occurs on a spinal as well as on a cortical level. The concept of the corticospinal reseve capacity describes a compensatory, increased recruitment of non primary motor areas and corticospinal disinhibition in order to preserve motor function. By detecting the degree of reorganization, a stratification for an unfavourable as well as stable clinical course could be made. This innovative approach to describe the pathomechanisms in CSM might revise current concepts of clinical diagnostics and might have an impact on future treatment strategies.

Interventions

Sponsors

German Spine Society (Deutsche Wirbelsäulenstiftung)
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
University Hospital of Cologne
CollaboratorOTHER
University Hospital Munich
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* patients with symptomatic/asymptomatic cervical spondylotic myelopathy scheduled for surgery (anterior and/ or posterior decompression) or conservative treatment. The radiological inclusion criteria are cervical spinal stenosis (C3-C7) associated with or without intramedullary high signal intensity lesion on T2-weighted MRI due to disc protrusion or spondylosis. * healthy subjects without any neurological disease

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Corticospinal reserve capacitypreoperativeComparison of corticospinal reserve capacity (defined by recruitment curve, cortical silent period, motor area) compared to healthy control group
Change in corticospinal reserve capacity9 months, 24 months postoperativelyPostoperative change in corticospinal reserve capacity compared to clinical symptoms

Countries

Germany

Contacts

Primary ContactAnna Zdunczyk, M.D.
anna.zdunczyk@charite.de004930450660193

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026